M.D., Ph.D., Director of the Rapid Medical Donation Program, Memorial Sloan Kettering Cancer Center
Dr. Donahue is a gastrointestinal pathologist interested in cancer genetics with a strong focus on pancreatic cancer. She is also a member of the David M. Rubenstein Center for Pancreatic Cancer Research. Her research interests include understanding the role of somatic mutations in DNA, the “genetic blueprint” of all living cells, in tumorigenesis, metastasis and treatment resistance. She is also the Director of the Rapid Medical Donation Program that empowers patients at their end of life to contribute to ongoing state of the art clinical research at Memorial Sloan Kettering Cancer Center.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Predicting clinical response to cancer therapies remains a major challenge in cancer treatment. Recent reports indicate that the tumor microenvironment and heterogeneity can limit the predictive power of current biomarker guided strategies. The panel will discuss new technologies that preserve these critical elements for better predictive value.